Data Sources Publications
ICR Logo
Wellcome logo undefined

Coronavirus Discovery resource

This is a Coronavirus research view of can SAR BLACK that we provide freely and openly to the research and drug discovery community to support them in the battle against Covid-19. This is a community resource and we invite the coronavirus research community to input (contact us)

can SAR is an integrated knowledgebase that brings together data across biology, chemistry, pharmacology, structural biology, cellular networks, and clinical annotations, and applies machine learning approaches to provide predictions useful for drug discovery and translational research.

Most data available in canSAR is agnostic of disease area and the resource is used widely outside of the oncology field. The Oncology-focused website is available @can SAR

Coronavirus Special Reports

ABOUT US

canSAR is developed by the canSAR Team | The Department of Data Science in collaboration with the Computational Biology and Chemogenomics team in the CRUK Cancer Therapeutics Unit at The Institute of Cancer Research, London.
This is a Coronavirus Edition of the canSAR knowledgebase to support the international effort against Covid-19.
canSAR is an integrated knowledgebase that brings together multidisciplinary data across biology, chemistry, pharmacology, structural biology, cellular networks and clinical annotations, and applies machine learning approaches to provide drug-discovery useful predictions.
canSAR’s goal is to enable translational research and drug discovery through providing this knowledge to researchers from across different disciplines. It provides a single information portal to answer complex multi-disciplinary questions and help hypothesis generation.
This is a free resource for the community. We invite collaborators to give feedback, input and contact us to ensure that we deliver what the translational research community needs.
Browser Compatibility: canSAR works on latest versions of Firefox, Chrome, Safari and Microsoft Edge.
Terms of Use: canSAR is freely available for all researchers. By using canSAR you are agreeing to these Terms of Use.
Data and stats: To view statistics of canSAR data please refer to the Data Sources.
Funding: canSAR is funded by the Cancer Research UK Drug Discovery Committee strategic award ‘canSAR: enhancing the drug discovery knowledgebase’ C35696/A23187.
We are also grateful to the Wellcome Trust Biomedical Resourcea Award to the Chemical Probes Portal (WT212969/Z/18/Z) and The Sir Henry Wellcome Postdoctoral Fellowship (WT 204735/Z/16/Z) for support. We thank the Heather Beckwith Charitable Settlement and The John L Beckwith Charitable Trusts for their generous support of our High-Performance Computing facility.

THE TEAM

CONTACT US

TERMS OF USE

1. canSAR is intended for use for scientific research only and cannot be used for the provision of medical advice. Please seek advice from your doctor if you have any queries about health conditions or drug treatments.
2. canSAR and canSAR-3D are freely available for use by any individual and for any purpose.
3. The ICR requires attribution for any tools or data from canSAR or canSAR-3d that are subsequently used in another product or service.
4. canSAR provides data collated from the public domain with references to their sources. The ICR cannot guarantee the accuracy of any data or databases nor their suitability for user purposes.
5. Software which can be run through canSAR may be used by any individual for any purpose unless specific exceptions are stated. The only exceptions with respect to software will be the prohibition of downloading, redistributing or re-engineering the software, and these exceptions only apply if explicitly stated.
6. In order to ensure optimum service and suitable future developments, the ICR will track usage statistics, with Google Analytics.
7. The ICR shall make every reasonable attempt to prevent breaches of that confidentiality. The ICR does not accept responsibility for the consequences of any breach of the confidentiality of the ICR site by third parties who by any means gain illegitimate access to information from canSAR or canSAR-3D.
8. Users of canSAR or canSAR-3D agree not to attempt to use any part of the ICR computers, files or networks apart from through the service interfaces provided. If any single organization/user exploits the ICR services to a level that prevents, or looks set to prevent, the ICR providing services to others, the ICR may discontinue service to that organization/user.
9. The ICR will make all reasonable effort to maintain continuity of service and provide adequate warning of any changes or discontinuities. However, the ICR accepts no responsibility for the consequences of any temporary or permanent discontinuity in service.
10. Any feedback on canSAR and canSAR-3D will be treated as non-confidential unless the individual or organisation providing the feedback states otherwise.
11. The ICR is not liable to the user or third parties claiming through the user, for any loss or damage of any kind whether direct or consequential.
12. Relevant law governing these terms and conditions is the law of England and Wales.
13. We will not, without good reason, alter these Terms of Use. Where alterations are inevitable, we will attempt to give reasonable notice of such alterations. However, we do reserve the right to alter these terms at any time in order to ensure their appropriateness to the ICR mission.